Investıgatıon Of The Effect Of The Pandemıc Process In Indıvıduals Wıth Chronıc Low Back And Neck Paın
Investıgatıon Of The Effect Of The Pandemıc Process On Cognıtıve Level, Paın Catastrophızatıon, Physıcal Actıvıty Level And Qualıty Of Lıfe In Indıvıduals Wıth Chronıc Low Back And Neck Paın
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 06200
- Hacettepe University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Those between the ages of 18-60,
- Having low back or neck pain lasting longer than 3 months,
- Having a history of Covid-19 (At least 6 weeks-post acute),
- Individuals with chronic low back and neck pain without a history of Covid-19 will be included.
Exclusion Criteria:
- Those with an active diagnosis of Covid-19
- Having a rheumatological disease,
- Broken etc. severe deformity that may lead to nerve injury,
- Having a history of spinal surgery,
- Having neurological disease in addition to spinal pathology,
- Having problems such as cancer, diabetes, dementia, organic brain dysfunction,
- Illiterate individuals will not be included.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Low back and neck pain group with experience of Covid-19
|
assessment of cognitive level, pain catastrophe, physical activity level and quality of life
|
|
Low back and neck pain group without experience of Covid-19
|
assessment of cognitive level, pain catastrophe, physical activity level and quality of life
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain Severity Assessment- Visual Analog Sacle
Time Frame: through study completion, an average of 1 year
|
VAS indicates the level of pain that the person is currently experiencing with a vertical line on a plane.
The pain felt by the person is marked as "0: I do not feel any pain", "10: I feel very severe pain".
Scoring is based on measuring the vertical marking of the participant for pain marked on the plane with a ruler.
The validity and reliability study of the scale was done by Price et al. made by
|
through study completion, an average of 1 year
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of Cognitive Level: Montreal Cognitive Assessment Scale (MOCA)
Time Frame: 5 minutes, through study completion, an average of 1 year
|
The scale consists of 11 questions in total.
The score range is 0-30.
Below 21 points is interpreted as cognitive disability for the Turkish population.
Turkish validity and reliability study was conducted by Selekler et al. made by
|
5 minutes, through study completion, an average of 1 year
|
|
Evaluation of Pain Catastrophization Level: Pain Catastrophization Scale
Time Frame: 5 minutes, through study completion, an average of 1 year
|
There are 13 questions in total on this scale.
The questions are aimed at questioning the feelings and thoughts of individuals during pain.
Each question scores between 0 and 4. A score of 30 and above indicates the presence of pain catastrophization.
The validity and reliability study of the Turkish version of the scale was conducted by Süren et al. made by.
|
5 minutes, through study completion, an average of 1 year
|
|
Assessment of Physical Activity Level: International Physical Activity Questionnaire (UFAA)-Short Form
Time Frame: 5 minutes, through study completion, an average of 1 year
|
It was developed by Craig, Marshall, Sjostrom, Bauman, and Booth (2003) by conducting validity and reliability studies of individuals in 12 different countries.
The questionnaire is a valid tool developed to determine the physical activity levels of individuals between the ages of 18-65.
There are eight versions of the questionnaire, which was adapted into Turkish by Öztürk (2005).
It has been developed as four short and four long forms.
The short form "last 7 days" was used in this study.
The short form (7 questions) provides information about time spent walking, moderate-to-vigorous and vigorous activities.
The time spent sitting is considered as a separate question.
It is classified as low, medium and high level by calculating the activity level of the person in terms of METs according to the duration, frequency and intensity level of the movement.
|
5 minutes, through study completion, an average of 1 year
|
|
Quality of Life Assessment: SF-36
Time Frame: 5 minutes, through study completion, an average of 1 year
|
SF-36 is a 36-item scale that evaluates the health status of a person with 8 sub-items (physical function, role limitations, social function, mental health, vitality, pain, general health).
Each sub-item is scored separately between 0-100.
As the score approaches 100, it indicates good health.
Turkish validity and reliability study, Koçyiğit et al. (1999).
|
5 minutes, through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 16969557-1040
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.